Alessa Therapeutics

San Carlos, CA · Founded 2018 · Privately Held (backing)

Developer of a drug delivery implantable system designed to treat patients with prostate cancer. Alessa Therapeutics is based in San Carlos, CA and was founded in 2018. It was valued at $49 million at its later-stage round in Apr 2025, the last priced event on record. It has raised $31.6 million across 3 recorded rounds; the latest was a $25.4 million early-stage round in Apr 2025.

PMV mark · valuation
$49.0M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$31.6M
Last round
Early Stage VC
Apr 2025

Who backs Alessa Therapeutics?

10 investors
InvestorType
National Institutes of HealthOther
Mission BioCapitalVenture capital
University of California San Francisco FoundationOther
Cure Ventures—
Johnson & Johnson—
MBC BioLabs—
Mission Bay Capital—
QB3—
UCI Beall Applied Innovation—
iO life ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Alessa Therapeutics investors

10 investors are on record for Alessa Therapeutics, including National Institutes of Health, Mission BioCapital, University of California San Francisco Foundation and Cure Ventures. The early-stage round in Apr 2025 drew 14 investors.

Free account
More of Alessa Therapeutics with a free account
  • ·Watch Alessa Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Alessa Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View